BrainCool Rights Issue Oversubscribed

BrainCool announces the outcome of its oversubscribed rights issue. The subscription period ended Dec 17, 2025. Results show 69,645,911 shares (82.46%) subscribed with rights. Consequently, the board resolved on a directed over-allotment issue to specific external investors to fulfill subscription commitments.

#BrainCool #medtech #lifescience #rightsissue

BrainCool Reports Oversubscribed Rights Issue

The subscription period ended Dec 17, 2025. 69,645,911 shares (approx 82.46%) were subscribed via rights. Due to oversubscription, the board resolved to utilize part of the over-allotment option through a directed issue to secure allocation for external investors with commitments.

#BrainCool #medtech #lifescience #rightsissue